RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Kansas City, KS · Topeka, KS · +85 more sites
6 recruiting crohn's disease studies with a site in Topeka, KS.
Sponsor: Merck Sharp & Dohme LLC
Kansas City, KS · Topeka, KS · +85 more sites
Sponsor: Eli Lilly and Company
Topeka, KS · +13 more sites
Sponsor: Eli Lilly and Company
Topeka, KS · +13 more sites
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Hays, KS · Kansas City, KS · +48 more sites
Sponsor: Janssen Research & Development, LLC
Topeka, KS · +38 more sites
Sponsor: Takeda
Kansas City, KS · Topeka, KS · +39 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.